The National Institutes of Health announced a massive new study Friday to test 3 immune modulators as potential COVID-19 treatments.
Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs.
